Post by Boulder BioMed

What does it take to move a medical device from years of stalled development to FDA clearance and market release? After years of development challenges and failed attempts at obtaining FDA clearance, Embolization Inc, Inc. partnered with Boulder BioMed to take a more integrated approach to commercialization. What began as a sterilization services engagement evolved into full support across regulatory affairs, manufacturing, engineering, quality systems, and operational leadership. The result? FDA 510(k) clearance in 2025 and successful limited market release of the novel NED embolic coil technology. This case study highlights the value of having a single-source partner to help navigate the complexities of medical device development — from concept through commercialization. 📖 Read the full case study to learn how Boulder BioMed helped turn years of roadblocks into a successful market launch. #MedTech #MedicalDevices #FDA #510k #MedicalDeviceDevelopment #Commercialization #HealthcareInnovation